Rocket Lab Secures Three New Electron Launches from iQPS

RKLB
April 10, 2026

Rocket Lab has secured a new multi‑launch agreement with the Institute for Q‑shu Pioneers of Space (iQPS), adding three dedicated Electron launches that will begin in 2028. The contract brings iQPS’s total Electron missions to 15, extending the partnership through 2028 and reinforcing Rocket Lab’s position as a primary launch provider for the growing small‑satellite constellation market.

iQPS, a Japanese synthetic‑aperture‑radar satellite operator, is building a 36‑satellite constellation to deliver near‑real‑time Earth observation. Each of the new launches will deploy iQPS’s QPS‑SAR satellites using Rocket Lab’s Motorized Lightband separation system, and all flights will launch from Launch Complex 1 in New Zealand.

The deal expands Rocket Lab’s customer base and adds to its order book. The company’s Q4 2025 backlog reached $1.85 billion, a 73% year‑over‑year increase, underscoring the contract’s material contribution to future revenue and the company’s growth trajectory.

Rocket Lab has already completed seven iQPS launches since 2023, all of which were successful. The new agreement extends the partnership through 2028, reinforcing confidence in Rocket Lab’s reliability and execution record.

"Our expanded partnership with iQPS is built on our consistent execution across the many missions we've launched for them already, and we're proud to continue delivering their Earth‑imaging constellation to space as we deepen our role as their primary launch provider," said Brian Rogers, Vice President of Global Launch Services.

Similar multi‑launch agreements have historically been well received by investors, reflecting confidence in Rocket Lab’s growth strategy and the broader small‑satellite market.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.